Hannah Kerr-Peterson's practice focuses on the pharmaceutical and medical devices sectors, where she advises on UK and EU regulatory and contentious matters. Ms. Kerr-Peterson has experience advising on a broad range of issues which can develop over the course of a medicinal product's life cycle, including drug development, clinical trials, authorisation, pricing and reimbursement, pharmacovigilance and product liability.

Before joining the firm, Ms. Kerr-Peterson conducted pre-clinical research at a leading European research institute. She has also spent time in-house in the regulatory litigation team of a major aircraft manufacturer, where she predominantly assisted with international trade disputes.

Ms. Kerr-Peterson has a varied pro bono practice, where she has assisted a junior bank manager in respect of enforcement proceedings which were being pursued by the Financial Conduct Authority, and most recently an employment tribunal case regarding discriminatory treatment of a long-term employee. Ms. Kerr-Peterson is also an active member of the firm's Diversity Committee.


  • Amicus Therapeutics, Inc. (Case T-33/17) in a dispute concerning transparency of clinical trial data and access to documents held by the European Medicines Agency.
  • Global pharmaceutical company in an internal investigation following its identification of failures in its pharmacovigilance system.
  • Senior executives of a global pharmaceutical company in relation to an investigation into alleged bribery and corruption.
  • Advising pharmaceutical companies in relation to promotional activities: advising on compliance with EU and UK legislation and industry codes of practice; and coordinating multi-jurisdictional projects.
  • Major aircraft manufacturer in a contract dispute concerning misrepresentation, negligent misstatement and breach of contract.


Life Sciences (UK) 2019 (pdf)
Chambers Global Practice Guide
2019 Regulatory Boot Camp
Arnold & Porter's Future Pharma Forum, London, United Kingdom
MHRA's updated guidance on a hard-Brexit
BioSlice Blog
MedTech Europe requests extension to the transition period for the MDR
BioSlice Blog
Update to ABHI Code of Practice
BioSlice Blog


  • Legal Practice Course, The University of Law, 2015
  • Graduate Diploma in Law, BPP University, London, 2013
  • BSc (Hons), Pharmacology and Molecular Genetics, King's College London, 2012
  • England and Wales

Email Disclaimer